The ME/CFS Collaborative Research Center operates within the Stanford Genome Technology Center. The research is directed by Dr. Ronald W. Davis, PhD, Professor of Biochemistry and Genetics and Director of the Stanford Genome Technology Center. The scientists work in collaboration with scientists and doctors from many disciplines, from all over the world. Similarly, for research on ME/CFS, we recruit world class scientists and doctors with different specialties for collaborations or to fund their independent work. This disease affects many systems of the human body, requiring a diversity of knowledge to unlock its secrets. Increasing the diversity of specialties of the researchers will mean that all aspects of this disease are considered in our effort to understand ME/CFS at the molecular level, not just the “symptom” level. Thus, the Center will increase the participation of the mainstream scientific community in ME/CFS. Involving well known prestigious university and research institute scientists with a track record of government funding will not only impact ME/CFS directly by generating new knowledge, but will also have a ripple effect in generating awareness and legitimacy for this devastating disease. The Center is dedicated to research of the highest quality with openly shared data (in compliance with confidentiality laws). This kind of research opens new opportunity for discovery, since it will utilize state-of-the-art methods and technologies that have never before been applied to ME/CFS, and will employ a collaborative, multi-disciplinary approach, which will investigate all aspects of ME/CFS in a comprehensive manner. Davis, who already has demonstrated success in this approach, is uniquely positioned to spearhead this attack on ME/CFS at the molecular level.
